Manhattan skyline at dusk, home to New York family offices investing in biotech

10 New York Family Offices Investing in Biotech (2026)

Subscribe to continue reading

Here are ten active family offices from our database that are based in New York and invest in biotech, along with their websites:

  1. Cedar Holdings (New York)
    Cedar Holdings is a family office with a global mandate to invest in innovative companies across public and private markets, mainly in healthcare and technology. With more than $750 million in assets and offices in New York, Boston, and London, it backs biotechnology, pharmaceutical, medical device, and diagnostic companies at various stages of their lifecycle.
  2. Polis Capital (New York)
    Polis Capital draws on a network of clinicians and CEOs of large healthcare and technology companies. The family office invests in AI, industrial technology, diagnostics, and biotech, and has held positions in private-market companies such as SpaceX and OpenAI.
  3. LCA Capital (New York)
    LCA Capital is a multigenerational Latin American family office with bases in New York and Mexico City and operating businesses in infrastructure, real estate, hotels, and self-storage. Its flexible mandate covers venture capital, life science, GP stakes, and structured credit.
  4. Winklevoss Capital (New York)
    Winklevoss Capital is the family office of Cameron and Tyler Winklevoss. It supports early-stage entrepreneurs with capital, guidance, and relationships, and its interests include biotech, space, and energy.
  5. First Haven Capital (New York)
    First Haven Capital is the direct-investment affiliate of the Turtle Creek family office, based in New York. It targets non-control equity stakes in lower-middle-market companies alongside high-quality sponsors, and its patient capital base supports long hold periods and growth, including in the life sciences.
  6. Ridgeback Capital (New York)
    Ridgeback Capital was started in 2006 by Wayne Holman, MD. The actively managed private investment company combines securities trading with long-term private investment and specializes in life science companies, both private and public.
  7. Upsher Management Company (New York)
    Upsher Management Company is a New York City single family office stretching across five generations, with origins in the early 1960s sale of the family's healthcare operating business to one of the world's largest pharmaceutical conglomerates. Its investment domains include biotech, healthcare, and pharmaceuticals within a broad multi-asset portfolio.
  8. MacAndrews & Forbes (New York)
    MacAndrews & Forbes is wholly owned by Ronald O. Perelman. The office owns and operates a diversified portfolio of public and private companies, with biotech among its investment domains.
  9. Crede CapitalGroup (New York)
    Crede CapitalGroup is a family office with offices in Los Angeles, New York, and Beijing, providing capital directly to small-cap public companies with market capitalizations below $2 billion. Since its 2009 inception it has completed about 115 transactions committing more than $900 million, and biotech is among its focus areas.
  10. Coruscant (New York)
    Founded in 2020, Coruscant is a family office that invests primarily in direct private equity, venture capital, and alternative funds. It invests broadly across asset classes and strategies, with an emphasis on biotechnology, data analytics, quantitative trading, and blockchain.

For more information and listings of active family offices:

Back to blog